AEVI GENOMIC MEDICINE INC's ticker is GNMX and the CUSIP is 00835P105. A total of 77 filers reported holding AEVI GENOMIC MEDICINE INC in Q1 2017. The put-call ratio across all filers is 0.18 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $500,000 | – | 96,621 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 1,070,000 | $1,990,000 | 0.99% |
| 22NW, LP | 155,000 | $288,000 | 0.17% |
| SPHERA FUNDS MANAGEMENT LTD. | 405,000 | $753,000 | 0.15% |
| Broadfin Capital, LLC | 500,000 | $930,000 | 0.11% |
| DLD Asset Management, LP | 237,100 | $438,000 | 0.07% |
| Birchview Capital, LP | 68,000 | $126,000 | 0.07% |
| CARL DOMINO INC | 33,273 | $62,000 | 0.07% |
| R&F Capital Advisors LP | 84,268 | $157,000 | 0.04% |
| TFS CAPITAL LLC | 49,461 | $92,000 | 0.03% |
| SIMON QUICK ADVISORS, LLC | 24,390 | $45,000 | 0.03% |